Risk Prognosis in Selected Diseases and in the General Population14:20 – 14:40 Adding a prognostic biomarker til other assesments of the patients arriving with Dyspnea, MD Klas Gränsbo (Malmö, Sweden)14:40 – 15:00Monitoring of life style changes in a general population cohort, MD Thomas Huneck Haupt (Hvidovre, Denmark)

15:00 – 15:20 Coffee/Tea break

15:20 – 15:40 suPAR in children with pneumonia, Dr. August Wrotek (Warzaw, Poland)15:40 – 16:00 Debate – Which patients groups in the ED would benefit the most of having their suPAR level measured?